US › Healthcare

Biomotion Sciences Ordinary Shares (SLXN)

US · Healthcare · Biotechnology

$1.90-2.56%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-2.7M

Profit YoY

-57.5%

EPS

$-8.50

EPS estimate

$-12.90

EPS came in at -8.50 against a street estimate of -12.90 — a beat of 34.1%.

Key statistics

Market cap

$2.0M

Forward P/E

0.0

P/B

6.58

Book value

$0.86

EPS (TTM)

$-59.70

52-week high

$90.45

52-week low

$1.50

50-day MA

$3.19

200-day MA

$15.37

Beta

-0.26

Analyst view

Analysts rate Biomotion Sciences Ordinary Shares a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $60.00.

Shareholding

Insiders

24.16%

Institutions

1.79%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	0.24%
TWO SIGMA SECURITIES, LLC	0.14%
A. Montag & Associates Inc	0.03%
UBS Group AG	0.01%
Pflug Koory, LLC.	0.00%
JONES FINANCIAL COMPANIES LLLP	0.00%
SBI Securities Co Ltd	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Biomotion Sciences Ordinary Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.